Evidence map›Paper›PMID 35896710›Full record

ArticleInternational journal of obesity (2005)2022

Small fragments of hyaluronan are increased in individuals with obesity and contribute to low-grade inflammation through TLR-mediated activation of innate immune cells.

Mònica Romo, Cristina López-Vicario, Noelia Pérez-Romero, Mireia Casulleras, Ana Isabel Martínez-Puchol, Belén Sánchez, Roger Flores-Costa, José Alcaraz-Quiles, Marta Duran-Güell, Ainitze Ibarzábal and 3 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of obesity (2005), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Hyaluronan in cardiac disease: implications for the extracellular matrix beyond collagen.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Biodegradable scaffolds for enhancing vaccine delivery.Bioengineering & translational medicine · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Mònica RomoBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Cristina López-VicarioBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Noelia Pérez-RomeroGastroenterology Department, Hospital Universitari Mútua de Terrassa, Terrassa, Spain.
Mireia CasullerasBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Ana Isabel Martínez-PucholMolecular Biology CORE, Biomedical Diagnostic Center, Hospital Clínic, Barcelona, Spain.
Belén SánchezBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Roger Flores-CostaBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain.
José Alcaraz-QuilesBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Marta Duran-GüellBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Ainitze IbarzábalGastrointestinal Surgery Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Juan José EspertGastrointestinal Surgery Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Joan ClàriaBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Esther TitosBiochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS, Barcelona, Spain. etitos@clinic.cat.ORCID 0000-0002-2543-2243
Hospital Clínic de Barcelona · ESMútua Terrassa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimExtracellular matrix (ECM) components released during excessive fat mass expansion are considered potential endogenous danger/alarm signals contributing to innate immune system activation. The aim of the current study was to specifically measure plasma levels of low molecular weight (LMW) hyaluronan (HA) and to evaluate its role as pro-inflammatory damage-associated molecular pattern (DAMP) on leukocyte response in the context of human obesity. SUBJECTS AND

methodsParticipants were selected according to their body mass index (BMI, kg/m

resultsWe observed a statistically significant increase in the circulating levels of HA fragments of LMW in individuals with obesity which were consistent with significant up-regulated expression of the LMW HA synthesizing enzyme hyaluronan synthase-1 (HAS-1) in obese adipose tissue. Gene expression assessment of HA receptors revealed up-regulated levels for TLR2 in both obese PMN and PBMC. Synthetic HA molecules of different sizes were tested on leukocytes from healthy donors. LMW HA fragments (15-40 kDa) and not those from intermediate molecular sizes (75-350 kDa) induced a significant up-regulation of the expression of major pro-inflammatory cytokines such as IL-1β, MCP-1 and IL-8 in PBMC. Importantly, LMW HA was able to induce the phosphorylation of IKK α/β complex supporting its pro-inflammatory role through NF-κB activation.

conclusionCirculating LMW HA molecules are elevated in obesity and may play an important role in triggering low-grade inflammation and the development of metabolic complications.

Indexed as

Hyaluronic AcidToll-Like Receptor 2CytokinesFicollHumansHyaluronan SynthasesI-kappa B KinaseImmunity, InnateInflammationInterleukin-8Leukocytes, MononuclearNF-kappa BObesityCytokinesFicollHyaluronan SynthasesHyaluronic AcidI-kappa B KinaseInterleukin-8NF-kappa BToll-Like Receptor 2

Identifiers

PMID35896710
PMCPMC9584819
OpenAlexW4288726188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.